NEW CentoXome® – Turning Our Expertise Into Your Advantage
In this webinar, Dr. Aida M. Bertoli-Avella, M.D., Head of Research Data Analysis, and Dr. Jorge Pinto Basto, M.D., Senior Medical Director, at CENTOGENE recently discussed the power of NEW CentoXome in Clinical Dx and shared insights into the diagnostic successes through CENTOGENE’s case studies.
Here’s What We Covered:
- CENTOGENE’s Mission
- Dx Power of NEW CentoXome
- Success of NEW CentoXome - Clinical Cases
- Our Life-Long Support
Fill in the form to watch the CentoTalk on demand
Dr. Aida M. Bertoli-Avella, Head of Research Data Analysis
Aida graduated from the Institute of Medical Sciences, Santiago de Cuba. In 2004, she obtained her Ph.D. in Human Genetics at the Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, the Netherlands...
... She received several grants and was a recipient of the prestigious Erasmus Fellowship in 2009. Major research accomplishments include the discovery of mutations in several genes causing congenital cardiovascular diseases, which led to new diagnostic tests, improved patient care guidelines, and major scientific publications.
After 18 years of experience in academia, she joined CENTOGENE, where she now serves as Head of Research Data Analysis.
Dr. Jorge Pinto Basto, Senior Medical Director
Jorge serves as CENTOGENE’s Senior Medical Director. Bringing in over 15 years of leadership experience, he is responsible for overseeing policies,...
...management, and regulations to drive clinical and operational value.
Before joining CENTOGENE, Jorge served as the Director of the Molecular Diagnostics and Genomics Labs at CGC Genetics. He holds a medical degree from the University of Porto and is specialized in Rare Disease Genetics, Neurogenetics, Dysmorphology, and Molecular Genetics.
Jorge is also the President of the Portuguese Society of Human Genetics.